N1-(3,4-dimethoxyphenethyl)-N6-phenethyladipamide(WXG02106)

Uses

N-[2-(3,4-Dimethoxyphenyl)ethyl]-N''-(2-phenylethyl)-hexanediamide is an intermediate of Dopexamine (D533900), which is a synthetic dopamine analog and acts as a a β2-adrenergic receptor agonistt as well as an agonist at peripheral dopamine receptors. Dopexamine has been used to improve myocardial and renal performance in patients suffering from low cardiac output states.